SCHEMBL29704368

SCHEMBL29704368

Cc1n[nH]c(C)c1-c1ccc(CNC(=O)OC(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ NAMPT P43490 2/20 0.44
▸ P2RX7 Q99572 2/20 0.44
▸ HDAC1 Q13547 1/20 0.43
▸ AKT1 P31749 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ CHEK1 O14757 1/20 0.42
▸ AKT2 P31751 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ SDCBP O00560 1/20 0.41
▸ SDC2 P34741 1/20 0.41
▸ IGF1R P08069 1/20 0.41
▸ GRM2 Q14416 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ PARP1 P09874 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29096629 0.80 CYP17A1 (0.49) NAMPTHDAC1CHEK1AKT2
SCHEMBL3180689 0.78 L3MBTL1 (0.61) L3MBTL1NAMPTHDAC1MAPTTDP1
SCHEMBL5796279 0.75 L3MBTL1 (0.56) L3MBTL1NAMPTHDAC1LMNAMAPT
SCHEMBL506891 0.75 CYP17A1 (0.61) L3MBTL1NAMPTHDAC1AKT1GAA
SCHEMBL7290389 0.75 NOTUM (0.54) L3MBTL1KDM4ELMNACYP1A2
SCHEMBL2567630 0.74 HDAC1 (0.57) L3MBTL1NAMPTHDAC1MAPTTDP1
SCHEMBL1691047 0.74 HDAC1 (0.67) L3MBTL1NAMPTHDAC1LMNAGAA
SCHEMBL15322811 0.74 NAMPT (0.50) L3MBTL1NAMPTHDAC1AKT1MAPT
SCHEMBL24088159 0.74 L3MBTL1 (0.50) L3MBTL1NAMPTHDAC1AKT1KDM4E
SCHEMBL22400217 0.74 NAMPT (0.50) L3MBTL1NAMPTHDAC1AKT1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4259144-A1 SMARCA DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-10-18 — — EP disclosed
WO-2022125804-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 — — WO disclosed
Send feedback